EC grants orphan drug designation to Dyne Therapeutics’ DMD therapy
The European Commission (EC) has granted orphan drug designation to Dyne Therapeutics’ DYNE-251 for treating Duchenne muscular dystrophy (DMD). This…
All articles by
-
-
Pharma companies in Europe push for US-level drug prices
Pharmaceutical companies in Europe are requesting the EU to adopt drug pricing strategies comparable to the US, as reported by…
-
Repertoire and Genentech to develop autoimmune disease therapies
Repertoire Immune Medicines has signed a partnership and licensing agreement with Roche’s Genentech, focusing on the discovery and development of…
-
Biogen’s Friedreich’s ataxia treatment authorised in UK
Biogen Netherlands has received marketing authorisation from the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) for its Skyclarys (omaveloxolone)…
-
EditCo Bio secures access to Promega’s technologies in licensing deal
EditCo Bio has entered a strategic licensing agreement with Promega, securing access to the latter’s protein-tagging and bioluminescent identification technologies.…
-
ConcertAI and Bayer to boost precision oncology with AI and ML insights
ConcertAI has announced an agreement that will allow Bayer to utilise its Translational360 and AI software-as-a-service (SaaS) solutions to expedite…
-
TNF and Renova Health use AI to identify patients for GLP-1 treatments
TNF Pharmaceuticals and Renova Health are set to use AI and machine learning for the identification of high-risk subjects who…
-
Regeneron partners with Fujifilm to broaden manufacturing capacity
Regeneron Pharmaceuticals has entered a new manufacturing and supply agreement with Fujifilm Diosynth Biotechnologies to broaden its capacity. Valued at…
-
DAAN Biotherapeutics and GC Cell partner for CAR-T, CAR-NK therapies
South Korea-based DAAN Biotherapeutics has entered a licensing agreement with GC Cell, granting the latter exclusive rights to leverage its…
-
Roche announces $50bn US investment in pharma and diagnostics
Roche is set to invest $50bn in pharmaceuticals and diagnostics in the US over the next five years to bolster…